These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 22182854)

  • 1. Src inhibitors, PP2 and dasatinib, increase retinoic acid-induced association of Lyn and c-Raf (S259) and enhance MAPK-dependent differentiation of myeloid leukemia cells.
    Congleton J; MacDonald R; Yen A
    Leukemia; 2012 Jun; 26(6):1180-8. PubMed ID: 22182854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dasatinib synergizes with ATRA to trigger granulocytic differentiation in ATRA resistant acute promyelocytic leukemia cell lines via Lyn inhibition-mediated activation of RAF-1/MEK/ERK.
    Ding M; Weng XQ; Sheng Y; Wu J; Liang C; Cai X
    Food Chem Toxicol; 2018 Sep; 119():464-478. PubMed ID: 29097117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roscovitine enhances All-trans retinoic acid (ATRA)-induced leukemia cell differentiation: Novel effects on signaling molecules for a putative Cdk2 inhibitor.
    Rashid A; Duan X; Gao F; Yang M; Yen A
    Cell Signal; 2020 Jul; 71():109555. PubMed ID: 32032659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of c-Cbl and p85 PI3K driven by all-trans retinoic acid and CD38 depends on Lyn kinase activity.
    Congleton J; Shen M; MacDonald R; Malavasi F; Yen A
    Cell Signal; 2014 Jul; 26(7):1589-97. PubMed ID: 24686085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GW5074 and PP2 kinase inhibitors implicate nontraditional c-Raf and Lyn function as drivers of retinoic acid-induced maturation.
    Jensen HA; Bunaciu RP; Varner JD; Yen A
    Cell Signal; 2015 Aug; 27(8):1666-75. PubMed ID: 25817574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Src-family kinase inhibitor PP2 rescues inducible differentiation events in emergent retinoic acid-resistant myeloblastic leukemia cells.
    Jensen HA; Styskal LE; Tasseff R; Bunaciu RP; Congleton J; Varner JD; Yen A
    PLoS One; 2013; 8(3):e58621. PubMed ID: 23554907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raf-1 kinase activation is uncoupled from downstream MEK/ERK pathway in cells treated with Src tyrosine kinase inhibitor PP2.
    Lee M
    Biochem Biophys Res Commun; 2006 Nov; 350(2):450-6. PubMed ID: 17010316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MEK/ERK dependent activation of STAT1 mediates dasatinib-induced differentiation of acute myeloid leukemia.
    Fang Y; Zhong L; Lin M; Zhou X; Jing H; Ying M; Luo P; Yang B; He Q
    PLoS One; 2013; 8(6):e66915. PubMed ID: 23825585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissecting the novel partners of nuclear c-Raf and its role in all-trans retinoic acid (ATRA)-induced myeloblastic leukemia cells differentiation.
    Rashid A; Wang R; Zhang L; Yue J; Yang M; Yen A
    Exp Cell Res; 2020 Sep; 394(1):111989. PubMed ID: 32283065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency of Fyn protein is prerequisite for apoptosis induced by Src family kinase inhibitors in human mesothelioma cells.
    Eguchi R; Kubo S; Takeda H; Ohta T; Tabata C; Ogawa H; Nakano T; Fujimori Y
    Carcinogenesis; 2012 May; 33(5):969-75. PubMed ID: 22354875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 6-Formylindolo (3,2-b)carbazole (FICZ) enhances retinoic acid (RA)-induced differentiation of HL-60 myeloblastic leukemia cells.
    Bunaciu RP; Yen A
    Mol Cancer; 2013 May; 12():39. PubMed ID: 23656719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of midostaurin and ATRA exerts dose-dependent dual effects on acute myeloid leukemia cells with wild type FLT3.
    Lu H; Weng XQ; Sheng Y; Wu J; Xi HM; Cai X
    BMC Cancer; 2022 Jul; 22(1):749. PubMed ID: 35810308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoic acid increases amount of phosphorylated RAF; ectopic expression of cFMS reveals that retinoic acid-induced differentiation is more strongly dependent on ERK2 signaling than induced GO arrest is.
    Yen A; Varvayanis S
    In Vitro Cell Dev Biol Anim; 2000 Apr; 36(4):249-55. PubMed ID: 10852350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Src family kinase inhibitor PP2 enhances differentiation of acute promyelocytic leukemia cell line induced by combination of all-trans-retinoic acid and arsenic trioxide.
    Jung YS; Cheong HJ; Kim SJ; Kim KH; Lee N; Park HS; Won JH
    Leuk Res; 2014 Aug; 38(8):977-82. PubMed ID: 24953245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferation and survival signaling from both Jak2-V617F and Lyn involving GSK3 and mTOR/p70S6K/4EBP1 in PVTL-1 cell line newly established from acute myeloid leukemia transformed from polycythemia vera.
    Nagao T; Kurosu T; Umezawa Y; Nogami A; Oshikawa G; Tohda S; Yamamoto M; Miura O
    PLoS One; 2014; 9(1):e84746. PubMed ID: 24404189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dasatinib on SRC kinase activity and downstream intracellular signaling in primitive chronic myelogenous leukemia hematopoietic cells.
    Konig H; Copland M; Chu S; Jove R; Holyoake TL; Bhatia R
    Cancer Res; 2008 Dec; 68(23):9624-33. PubMed ID: 19047139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGFR inhibitors exacerbate differentiation and cell cycle arrest induced by retinoic acid and vitamin D3 in acute myeloid leukemia cells.
    Lainey E; Wolfromm A; Sukkurwala AQ; Micol JB; Fenaux P; Galluzzi L; Kepp O; Kroemer G
    Cell Cycle; 2013 Sep; 12(18):2978-91. PubMed ID: 23974111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of Raf-1 and mitogen-activated protein kinases during monocytic differentiation of human myeloid leukemia cells.
    Kharbanda S; Saleem A; Emoto Y; Stone R; Rapp U; Kufe D
    J Biol Chem; 1994 Jan; 269(2):872-8. PubMed ID: 8288641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined Inhibition of IGF-1R/IR and Src family kinases enhances antitumor effects in prostate cancer by decreasing activated survival pathways.
    Dayyani F; Parikh NU; Varkaris AS; Song JH; Moorthy S; Chatterji T; Maity SN; Wolfe AR; Carboni JM; Gottardis MM; Logothetis CJ; Gallick GE
    PLoS One; 2012; 7(12):e51189. PubMed ID: 23300537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines.
    Miranda MB; McGuire TF; Johnson DE
    Leukemia; 2002 Apr; 16(4):683-92. PubMed ID: 11960350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.